Key facts
- This page summarizes Peter Richard Orszag's Form 4 filing for Lazard, Inc. (LAZ).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Sep 2025, 20:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Disposed to Issuer
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Shares of Common Stock were acquired upon the exchange of a prior grant of Restricted Stock Units ("RSUs") into shares of Common Stock.
Footnote F2
Represents shares of Common Stock sold to the Company to cover estimated taxes.
Footnote F3
Represents the New York Stock Exchange closing price of Common Stock on the trading day immediately preceding the exchange date of the RSUs referenced in Footnote (6).
Footnote F4
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures.
Footnote F5
The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on September 16, 2025 in trades with average execution prices ranging from $53.76 to $54.53 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.
Footnote F6
Represents a prior grant of RSUs awarded for which service and other conditions have been satisfied.
Footnote F7
Each RSU represents a contingent right to receive one share of Common Stock.
Footnote F8
Amount excludes a prior grant of 1,250,000 Stock Price Performance-based Restricted Participation Units and 306,546 Restricted Participation Units, each of which was reflected in the Company's proxy statement for the relevant year.